SBIR/STTR Research Award

Genotyped and Single Cyst-derived Human ADPKD Cell Platforms for Industry and Academia

Award identifier 1cfef667777d3a0adba4cb054cd7049c6ce47674bd6168688900b0bfa5a11ac3Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$838,880

Program and phase

SBIR · Phase II

Award year

2017

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
DISCOVERYBIOMED, INC.
Proposal award date
2017-05-05
Contract end date
2019-04-30
UEI
LR7QH452JJ31
Solicitation number
PA15-052
Topic code
100

Research abstract

DiscoveryBioMedIncDBMIncor DBMspecializes in normal and diseased human cell platform engineeringDBM has assembled a consortium of expertswherebycollectivelywe seek Fast Track SBIR funding to establish and offer a Product Line Menu of normal and ADPKD human cell platforms for the academic and industry marketplacesExisting and interested DBM clients will be presented in terms of which options in the Product Line Menu fit their research needsas highlighted in our Research Strategy and Commercialization PlanThis highly anticipated Product Line Menu will include an array ofaspecialty cell culture componentsbprimary normal and ADPKD human primary culturescmixed immortal cultures anddclonal immortal cell lines that are well characterizedgenotypedand defined as to nephron segment of originImmortal cell lines will be compared to the primary cultures from which they were derived to determine whether they are similar in bioassay performancein genotypeand in nephron segment of originDBM and collaborators have begun the collection and characterization ofsingle cyst derived primary cultures andmulticystic tissue derived primary cultures fromhuman ADPKDhuADPKDdonor kidneysprocured from commercial vendorsin pilot Phaselike studiesThese initialhuADPKD primary cultures were combined with primary cultures fromdifferent donors from DrDarren Wallace s PKD Research Biomaterials and Cellular Models Core at Kansas University Medical CenterKUMCso that allsamples could be genotyped by DrPeter HarrisCore at the Mayo PKD CenterEach huADPKD primary culture has been profiled inD microtiter plate driven proliferation bioassays on tissue culture plastic as well as inD Matrigel based cystogenesis bioassaysPreliminary data are presented in support of the above pilot effortsSelect primary cultures that display a compelling genotype and exhibit excellent utility inD andD bioassays will be immortalized by multiple genetic methodsDBM has pledged to also immortalize KUMC primary cultures as necessary in collaborationWhere possiblenephron segment of origin will be identified in huADPKD cellsTwo hypotheses will be addressed within our applied science researchDoes primary huADPKD fibroblast supportco cultureconditioned mediumbothdrive human ADPKD cystic epithelial cell primary cultures to be longer lived and or to attain specific phenotypes inD andD bioassays for PKD researchandDo individual cysts within a given huADPKD donor kidney possess the same genotype or can they differ in genotype from cyst to cysti eexploring theone hitvstwo hithypothesis or the emergence of somatic mutations and the possible presence of haploinsufficiencyDBM et alsetmilestones for our work to be supported by this possible Fast Track SBIR awardMilestonewill be the establishment of single cyst derived and multicystic tissue derived primary cultures from each huADPKD donor kidney tissue sample and with a final goal ofdifferent donors processedMilestonewill be to genotype each individual cyst derived and multicystic tissue derived primary culturecompare genotypes against the ADPKD genotype databaseand select candidate primary cultures for immortalizationMilestonewill be to immortalize select primary cultures using a well optimized Critical PathMilestonewill be to characterize immortal clonal cell lines versus primary cultures wherefrom the cell lines originated to determineusabilityin different bioassaysMilestonewill be to offer custom packages of human normal and ADPKD kidney cell platforms from our Product Line Menu to the PKD academic and industry research communities in Yearsandof the award and beyond this term as a self sustaining business

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

19 SBIR/STTR records share this UEI (2008–2020). Reported award amounts total $11,512,428. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.